Details for Patent: 8,916,195
✉ Email this page to a colleague
Which drugs does patent 8,916,195 protect, and when does it expire?
Patent 8,916,195 protects CONTRAVE and is included in one NDA.
This patent has twelve patent family members in six countries.
Summary for Patent: 8,916,195
Title: | Sustained release formulation of naltrexone |
Abstract: | A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition. |
Inventor(s): | McKinney; Anthony A. (San Diego, CA), Tollefson; Gary D. (Indianapolis, IN), Soltero; Richard (Holly Springs, NC), Dunzo; Thea Elise (Durham, NC) |
Assignee: | Orexigen Therapeutics, Inc. (La Jolla, CA) |
Application Number: | 11/757,773 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,916,195 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; |
Drugs Protected by US Patent 8,916,195
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE OF NALTREXONE AND BUPROPION IN EXTENDED-RELEASE FORM FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,916,195
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 061233 | ⤷ Sign Up | |||
European Patent Office | 2061448 | ⤷ Sign Up | |||
European Patent Office | 3626236 | ⤷ Sign Up | |||
Spain | 2749800 | ⤷ Sign Up | |||
Japan | 2009539837 | ⤷ Sign Up | |||
Japan | 2014005310 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |